youtube_live
Q3 2026 earnings • released • EPS beat +29.20% • Revenue beat +1.99%
See resultschevron_right
ACHC:NASDAQ
Acadia Healthcare Company Inc
$37.00
arrow_upward
+6.35%(+2.21) 1D
$37.72
arrow_upward
+1.95% (+0.72)bedtimeAfter hours
Closed: Nov 6, 4:00:01 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ACHC...
Open
$35.18
High
$37.94
Low
$34.20
Mkt. cap
3.44B
Avg. vol.
1.80M
Volume
4.53M
52-wk high
$39.38
52-wk low
$11.43
EPS
-$12.48
Beta
0.64
Shares outstanding
92.97M
No. of employees
22K
Open
$35.18
High
$37.94
Low
$34.20
Mkt. cap
3.44B
Avg. vol.
1.80M
Volume
4.53M
52-wk high
$39.38
52-wk low
$11.43
EPS
-$12.48
Beta
0.64
Shares outstanding
92.97M
No. of employees
22K
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
Acadia Healthcare Company (ACHC) Could Be 77% Undervalued Following Raised 2026 Guidance
Yahoo Finance
·
9 hours ago
Acadia Healthcare (ACHC) Stock May Still Sit Below Fair Value Following Raised 2026 Guidance
Investing.com
·
1 day ago
RBC Capital raises Acadia Healthcare price target on margin beat
Profile
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
The company is headquartered in Franklin, Tennessee. As of 2024, Acadia operated over 50 inpatient psychiatric hospitals in 19 U.S. states, including Arizona, Arkansas, Florida, Georgia, Indiana, Michigan, Missouri, New Mexico, Ohio, Oklahoma, Pennsylvania, Tennessee, Utah, and Wisconsin. It is one of the country's largest hospital systems. It also operates, as of 2024, 165 methadone clinics in 33 states, making it the U.S.'s largest methadone-clinic chain.
Acadia was founded as a private corporation in 2005 by Reeve B. Waud and went public in 2011. Wikipedia
About Acadia Healthcare Company Inc
CEOChristopher H. Hunter
Employees22K
Founded2005
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websiteacadiahealthcare.com
Analyst ratings
Based on 11 analysts giving stock ratings to ACHC in the past 3 months
Buy
Buy
6
Hold
4
Sell
1
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for ACHC in the last 3 months.
Highest
Current $37.00
$45.00 (+21.62%)
Average
$38.90 (+5.14%)
Lowest
$33.00 (-10.81%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Ben Hendrix RBC Capital | Buy | Reiterated | $41.00 | +10.8% | 11/06/2026 |
Sarah James Cantor Fitzgerald | Hold | Maintained | $39.00 | +5.4% | 11/05/2026 |
A.J. Rice UBS | Buy | Maintained | $45.00 | +21.6% | 11/06/2026 |
Ryan Langston TD Cowen | Buy | Maintained | $40.00 | +8.1% | 11/06/2026 |
Ann Hynes Mizuho Securities | Hold | Maintained | $36.00 | -2.7% | 11/06/2026 |
Jason Cassorla Guggenheim | Buy | Maintained | $41.00 | +10.8% | 11/05/2026 |
Joanna Gajuk Bank of America Securities | Sell | Maintained | - | - | 11/05/2026 |
Andrew Mok CFA Barclays | Hold | Maintained | $35.00 | -5.4% | 11/05/2026 |
Andrew Cooper Raymond James | Buy | Maintained | $39.00 | +5.4% | 09/28/2026 |
Whit Mayo Leerink Partners | Hold | Reiterated | $33.00 | -10.8% | 09/23/2026 |
Brian Tanquilut Jefferies | Buy | Maintained | $40.00 | +8.1% | 09/17/2026 |
Matthew Gillmor CFA KeyBanc | Buy | Maintained | $40.00 | +8.1% | 07/30/2026 |
Unknown Analyst KeyBanc | Buy | Maintained | $40.00 | +8.1% | 07/14/2026 |
John Ransom Raymond James | Buy | Maintained | $39.00 | +5.4% | 05/04/2026 |
Pito Chickering Deutsche Bank | Buy | Maintained | $32.00 | -13.5% | 05/01/2026 |
Gary Taylor TD Cowen | Buy | Reiterated | $30.00 | -18.9% | 04/28/2026 |
Last report
Nov 5, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$0.60 / $0.46
+29.20%beat
arrow_upward
Revenue / Est. (USD)
895.31M / 877.85M
+1.99%beat
arrow_upward
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | 821.46M | 828.80M | 865.84M | 895.31M |
Cost of goods sold | 491.61M | 496.53M | 504.29M | 521.77M |
Cost of revenue | 491.61M | 496.53M | 504.29M | 521.77M |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 60.35M | 64.93M | 67.60M | 70.60M |
Operating expense | 282.21M | 248.44M | 273.78M | 259.47M |
Total operating expenses | 773.82M | 744.97M | 778.07M | 781.24M |
Operating income | 47.64M | 83.84M | 87.77M | 114.07M |
Other non operating income | -135.46M | -216.00K | -224.00K | -174.00K |
EBT including unusual items | -1.17B | 10.96M | 22.01M | 56.47M |
EBT excluding unusual items | -125.74M | 45.29M | 49.37M | 76.62M |
Income tax expense | 7.84M | 6.50M | 9.75M | 17.82M |
Effective tax rate | -0.67% | 59.28% | 44.29% | 31.55% |
Other operating expenses | 176.10M | 131.08M | 155.75M | 135.74M |
Net income | -1.18B | 4.10M | 10.93M | 34.49M |
Net profit margin | -143.34% | 0.50% | 1.26% | 3.85% |
Earnings per share | 0.07 | 0.37 | 0.38 | 0.60 |
Interest and investment income | - | - | - | - |
Interest expense | -37.92M | -38.33M | -38.18M | -37.28M |
Net interest expenses | -37.92M | -38.33M | -38.18M | -37.28M |
Depreciation and amortization charges | 45.75M | 52.43M | 50.43M | 53.13M |
EBITDA | 93.40M | 136.26M | 138.20M | 167.20M |
Gain or loss from assets sale | - | -1.22M | -2.36M | 189.00K |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events